Pharmaceutical giant Roche has tapped University of Wisconsin researcher ... s an important first step to see the reaction of cells they?ve isolated,? Kalil said. ?It?s a very good use for embryonic ...

Roche has largely been a spectator on the side lines as other drugmakers have embraced cell therapies for cancer, but it has made a big play now, pledging $150 million upfront to an alliance with ...

Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is ...